Dose- and time-dependent effects of 17β-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: Implications of IRS-1

Journal of Endocrinology

Volumn 176, Issue 3, 2003, Pages 367-379

  Gonzalez C ^a   Alonso, A ^a   Diaz F ^a   Patterson, A M ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INSULIN RECEPTOR SUBSTRATE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HORMONAL THERAPY; HORMONE ACTION; HYPERINSULINEMIA; INSULIN SENSITIVITY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; PHOSPHOPROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0037355541     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1760367     Document Type: Review

References (62)

1. Andersson B, Mattsson LA, Hahn L, Marin P, Lapidus L, Holm G, Bengtsson BA & Björntorp P 1997 Oestrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in post-menopausal women with non-insulin diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 82 638-643.
2. Araki E, Haag B, Matsuda K, Schichiri M & Kahn CR 1995 Characterization and regulation of the mouse insulin receptor substrate gene promoter. Molecular Endocrinology 9 1367-1369.
3. Barret-Connor E & Laakso M 1990 Ischaemic heart disease risk in post-menopausal women: effect of estrogen on glucose and insulin levels. Arterioesclerosis 10 531-534.
4. Beato M 1989 Gene regulation by steroid hormones. Cell 56 335-344.
5. Berlanga JJ, Gualillo O, Buteau H, Applanat M, Kelly PA & Edery M 1997 Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase. Journal of Biological Chemistry 272 2050-2052.
6. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. Analytical Biochemistry 72 248-254.
7. Brussard HE, Gevers Leuven JA, Frolich M, Kluft C & Krans HMJ 1997 Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40 843-849.
8. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P & Melis GB 1992 Effects of low doses of 17-β-estradiol on carbohydrate metabolism in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 74 1396-1400.
9. Carvalho CRO, Brenelli SL, Silva AC, Nunes ALB, Velloso LA & Saad MJ 1996 Effect of aging on insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in liver and muscle of rats. Endocrinology 137 151-159.
10. Carvalho E, Jansson PA, Axelsen M, Eriksson JW, Huang X, Groop L, Rondinone C, Sjostrom L & Smith U 1999 Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB Journal 13 2173-2178.
11. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
12. Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC & Chou FP 1999 Fluctuation of serum lipids after ovariectomy and the influence of estrogen supplement. Life Sciences 64 2299-2306.
13. Clark SF, Martin S, Carozzi AJ, Hill MM & James DE 1998 Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. Journal of Cell Biology 140 1211-1225.
14. Clark S, Molero JC & James DE 2000 Release of insulin receptor substrate 1 proteins from an intracellular complex coincides with the development of insulin resistance. Journal of Biological Chemistry 275 3819-1826.
15. Colacurci N, Zarcone R, Mollo A, Russo G, Passaro M, De Seta L & De Franciscis P 1998 Effect of hormone replacement therapy on glucose metabolism. Pannminerva Medicine 40 18-21.
16. Collison M, Campbell IW, Salt IP, Dominiczak AF, Connel JMC & Gould GW 2001 Sex hormones induce insulin resistance in 3Y3-L1 adipocytes by reducing cellular content of IRS-1 protein. Diabetologia 43 1374-1380.
17. DeFronzo RA & Ferrannini MD 1991 Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14 173-194.
18. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A & Licholai T 1992 Evidence for distinctive bad intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41 1257-1266.
19. Fagan TC & Deedwania PC 1998 The cardiovascular dysmetabolic syndrome. American Journal of Medicine 105 775-825.
20. Ferrara A, Karter AJ, Ackerson LM, Liu JY & Selby JV 2001 Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: the Northern California Kaiser Permanent Diabetes Registry. Diabetes Care 24 1144-1150.
21. Fineberg SE 2000 Glycaemic control and hormone replacement therapy. Implications of the postmenopausal estrogen/progestogen interventions (PEPI) study. Drugs and Aging 17 453-461.
22. Godsland IF 1996 The influence of female sex steroids on glucose metabolism and insulin action. Journal of Internal Medicine Supplement 738 1-60.
23. Goldfine ID 1987 The insulin receptor: molecular biology and transmembrane signalling. Endocrine Reviews 8 235-255.
24. González C, Díaz F, Fernández S & Patterson AM 1997 Role of 17-β-estradiol and progesterone on glucose homeostasis: effects of food restriction (50%) in pregnant and non-pregnant rats. Journal of Endocrinological Investigation 20 397-403.
25. González C, Díaz F, Fernández S & Patterson AM 1998 Pregnancy in rats and food restriction (50%): insulin response in relation to serum lipids and lipoprotein levels. Nutrition Research 18 1235-1244.
26. González C, Alonso A, Alvarez N, Diaz F, Martinez M, Fernández S & Patterson AM 2000 Role of 17β-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy. Journal of Endocrinology 166 283-291.
27. González C, Alonso A, Balbín M, Fernández S & Patterson AM 2002a Effects of pregnancy on insulin receptor in liver, skeletal muscle and adipose tissue of rats. Gynecological Endocrinology 16 193-205.
28. González C, Alonso A, Grueso NA, Esteban MM, Fernández S & Patterson AM 2002b Effects of treatment with different doses of 17-β-estradiol on the insulin receptor. Life Science 70 1621-1630.
29. Gosbell AD, Favilla I, Baxter KM & Jablonski P 2000 Insulin receptor and insulin receptor substrate-1 in rat retinae. Clinical and Experimental Ophthalmology 28 212-215.
30. Herrera E, Lasunción MA, Palacín M, Zorzano A & Bonet B 1991 Intermediary metabolism in pregnancy. First theme of the Freinkel Era. Diabetes 40 83-88.
31. Huang Z, Bodkin NL, Ortmeyer HK, Zenilman ME, Webster NJ, Hansen BC & Shuldiner AR 1996 Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies. Journal of Clinical Endocrinology and Metabolism 81 1152-1156.
32. Jensen MD, Martin ML, Cryer PE & Roust LR 1994 Effects of estrogen on free acid metabolism in humans. American Journal of Physiology 266 E914-E920.
33. Kaaks R & Lukanova A 2001 Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proceedings of the Nutrition Society 60 91-106.
34. Karjalainen A, Paassilta M, Heikkinen J, Bäckström A-C, Savolainen M & Kesäniemi YA 2001 Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism. Clinical Endocrinology 54 165-173.
35. Krauss RM, Perlman JA, Ray R & Petitti D 1988 Effect of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women. American Journal of Obstetrics and Gynecology 158 1606-1611.
36. Kristensen K, Pedersen SB & Richelsen B 1999 Regulation of leptin by steroid hormones in rat adipose tissue. Biochemical and Biophysical Research Communications 259 624-630.
37. Kumagai S, Holmang A & Björntorp P 1993 The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiologica Scandinavica 149 91-97.
38. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK & Yee D 1999 Enhancement of insulin-like growth factor signalling in human breast cancer: estrogen regulation of insulin-receptor substrate-1 expression in vitro and in vivo. Molecular Endocrinology 13 787-796.
39. Liang L, Jiang J & Frank SJ 2000 Insulin receptor-substrate 1-mediated enhancement of growth hormone-induced mitogen activated protein kinase activation. Endocrinology 141 3328-3336.
40. Lindheim SK, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ & Lobo KA 1993 A possible bimodal effect of estrogen on insulin sensitivitv in postmenopausal women and the attenuating effect of added progestin. Fertility and Sterility 60 664-667.
41. Lindheim SR, Duffy DM, Kojima TK, Vijoid MA, Stanczyk FZ & Lobo RA 1994 The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertility and Sterility 62 1176-1180.
42. Molloy CA, May F & Westley BR 2000 Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. Journal of Biological Chemistry 275 12565-12571.
43. Olson AL, Trumbly AR & Gibson GV 2001 Insulin-mediated GLUT4 translocation is dependent on the microtubule network. Journal of Biological Chemistry 276 10706-10714.
44. Polderman KH, Gooren LJ, Asscheman H, Bakker A & Heine RJ 1994 Induction of insulin resistance by androgens and estrogens. Journal of Clinical Endocrinology and Metabolism 79 265-271.
45. Rankin JHG, Jodarski G & Shanahan MR 1986 Maternal insulin and placental 3-O-methyl glucose transport. Journal of Developmental Physiology 8 247-253.
46. Reaven GM 1993 Role of insulin resistance in human disease (syndrome X): an expanded definition. Annual Review of Medicine 44 121-131.
47. Rincón J, Holmäng A, Odegaard Wahlström E, Lönnroth P, Björntorp P, Zierath JR & Wallberg-Henriksson H 1996 Mechanism behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45 615-621.
48. Saad MJA, Maeda L, Brenelli SL, Carvalho CRO, Paiva RS & Velloso LA 1997 Defects in insulin signal transduction in liver and in muscle of pregnant rats. Diabetologia 40 179-186.
49. Sattar N 1998 Hormone replacement therapy in type 2 diabetes mellitus: a cardiovascular perspective. Diabetic Medicine 15 631-633.
50. Sun XJ, Miralpeix M, Myers MG Jr, Glasheen EM, Backer JM, Kahn CR & White MF 1992 Expression and function of IRS-1 in insulin signal transmission. Journal of Biological Chemistry 267 22622-22672.
51. Szanto I & Kahn CR 2000 Selective interactions between leptin and insulin signalling pathways in a hepatic cell line. PNAS 97 2355-2360.
52. Towbin H, Staehlin J & Gordon J 1979 Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets. Procedure and some applications. PNAS 76 4350-4353.
53. Tremollieres FA, Pouilles JM & Ribot CA 1996 Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. American Journal of Obstetrics and Gynecology 175 1594-1600.
54. Troisi RJ, Cowie CC & Harris MI 2000 Oral contraceptive use and glucose metabolism in a national sample of women in the United States. American Journal of Obstetrics and Gynecology 183 389-395.
55. Virkamäki A, Ueki K & Kahn CR 1999 Protein-protein interactions in insulin signalling and the molecular mechanism of insulin resistance. Journal of Clinical Investigation 103 931-943.
56. Wade GN 1975 Some effects of ovarian sex hormones on food intake and body weight in female rats. Journal of Comparative Physiology and Psychology 88 1277-1283.
57. Wagner JC, Thomas MJ, Williams JK, Zhang L, Greaves KA & Cefalu WT 1998 Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined nomegestrol acetate. Journal of Clinical Endocrinology Metabolism 83 896-901.
58. Waters SB & Pessin JE 1996 Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave. Trends in Cell Biology 6 1-4.
59. White MF 1998 The IRS-signalling system: a network of docking proteins that mediate insulin action. Molecular and Cellular Biochemistry 182 3-11.
60. White MF & Kahn CR 1994 The insulin signalling system. Journal of Biological Chemistry 269 1-4.
61. Whitehead JP, Clark SF, Urso B & James DE 2000 Signalling through the insulin receptor. Current Opinion in Cell Biology 12 222-228.
62. Writing Group for the PEPI Trial 1995 Effects of estrogen or estrogen/progesten regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progesten interventions (PEPI) trial. Journal of the American Medical Association 273 199-208.